Trial NCT02076594

View at ClinicalTrials.gov 
Org. Study IDs: LEGA
Secondary IDs: 2011-005537-39

Last trial update was posted on 2019-10-09

MeSH Interventions

Capecitabine Docetaxel Epirubicin Oxaliplatin

MeSH Conditions

Stomach Neoplasms

Other Conditions

Locally Advanced Unresectable Gastric Cancer Metastatic Gastric Cancer

Stopping Reasons

The interim analysis performed on 09 November 2018, showed the failure to achieve the primary objective of effectiveness of the experimental treatment.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID